| 000 | 01739 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250511192230.0 | ||
| 264 | 0 | _c19920429 | |
| 008 | 199204s 0 0 eng d | ||
| 022 | _a0277-3732 | ||
| 024 | 7 |
_a10.1097/00000421-199204000-00003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoila, F | |
| 245 | 0 | 0 |
_aAntiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients. _h[electronic resource] |
| 260 |
_bAmerican journal of clinical oncology _cApr 1992 |
||
| 300 |
_a112-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aDacarbazine _xadverse effects |
| 650 | 0 | 4 |
_aDexamethasone _xtherapeutic use |
| 650 | 0 | 4 |
_aDiphenhydramine _xtherapeutic use |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aMethylprednisolone _xtherapeutic use |
| 650 | 0 | 4 |
_aMetoclopramide _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aSarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 700 | 1 | _aBracarda, S | |
| 700 | 1 | _aBasurto, C | |
| 700 | 1 | _aSassi, M | |
| 700 | 1 | _aLupattelli, M | |
| 700 | 1 | _aPicciafuoco, M | |
| 700 | 1 | _aBoschetti, E | |
| 700 | 1 | _aDel Favero, A | |
| 700 | 1 | _aTonato, M | |
| 773 | 0 |
_tAmerican journal of clinical oncology _gvol. 15 _gno. 2 _gp. 112-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000421-199204000-00003 _zAvailable from publisher's website |
| 999 |
_c1560380 _d1560380 |
||